Quantum-Si (QSI) Non Operating Interest Expenses (2020 - 2021)
Quantum-Si's (QSI) quarterly Non Operating Interest Expenses came in at $5000.0 in Q2 2021, up 400.0% year-over-year from $1000.0 in Q2 2020, and up 25.0% quarter-over-quarter from $4000.0 in Q4 2020.
Powered by 
Analysis
Quantum-Si (QSI) Non Operating Interest Expenses (2020 - 2021) Analysis & Trends
Quantum-Si (QSI) has reported Non Operating Interest Expenses for 2 consecutive years, with $5000.0 the latest figure, recorded in Q2 2021.
- On a quarterly basis, Non Operating Interest Expenses rose 400.0% year-over-year to $5000.0 in Q2 2021; TTM through Jun 2022 was $5000.0, a 64.29% decrease from a year earlier, with the FY2021 full-year figure at $5000.0, down 44.44% from the prior year.
- Non Operating Interest Expenses was $5000.0 for Q2 2021 at Quantum-Si, up from $4000.0 in the prior quarter.
- Over five years, Non Operating Interest Expenses peaked at $5000.0 in Q2 2021 and troughed at $1000.0 in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 224.64 Bn | 220.58 Bn | 8.34 Bn | 401.00 Mn |
| 2 | Danaher | 144.47 Bn | 140.13 Bn | 3.61 Bn | 107.00 Mn |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 29.00 Mn |
| 4 | Illumina | 31.47 Bn | 30.30 Bn | 770.00 Mn | 24.00 Mn |
| 5 | Revvity | 13.70 Bn | 12.68 Bn | 416.87 Mn | 25.79 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 2.12 Mn |
| 7 | Bio-Rad Laboratories | 10.07 Bn | 8.45 Bn | 345.80 Mn | 12.10 Mn |
| 8 | Repligen | 9.45 Bn | 8.44 Bn | 110.04 Mn | 5.66 Mn |
| 9 | 10x Genomics | 8.64 Bn | 8.09 Bn | 112.50 Mn | - |
| 10 | Quantum-Si | 163.74 Mn | 163.74 Mn | 172,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 5,000.00 |
| Dec 31, 2020 | 4,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 1,000.00 |